StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 6/30
$2.71+0.04 (+1.50%)

Close on Nov 18, 2026Market cap $94.21MP/E –Yield –

Anixa Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Anixa Biosciences's price to sales ratio was 245.1× on Aug 31, 2022, against 243.2× a year earlier. Over the last 5 years it ranged from 2.1× to 288.7×, with a median of 86.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Aug 31, 2022245.1×+70.8
2021Dec 31, 2021174.3×−15.8
2020May 29, 2020190.1×−76.7
2019Dec 31, 2019266.8×+199.8
2018Dec 31, 201867.0×−41.1
2017Dec 29, 2017108.1×−49.4
2016Dec 30, 2016157.5×+154.7
2015Dec 31, 20152.8×−3.8
2014Dec 31, 20146.6×−95.7
2013Dec 31, 2013102.3×+66.8
2012Dec 31, 201235.4×+16.1
2011Dec 30, 201119.3×−24.9
2010Dec 31, 201044.2×–

More Anixa Biosciences figures

See a number that looks wrong?